A Simple Key For GM-CSF/CSF2 Protein Unveiled
123). It's notable that GLS2 is tumorigenic in breast cancer124, and its expression could compensate for loss of Gls in MYC-induced mouse liver tumours40. This means that GLS2 could confer resistance to GLS1-precise inhibitors, such as the allosteric inhibitor BPTES or CB-839, and this resistance may very well be hypothetically avoided by the usage